ResearcherGeorgetown UniversityNo recent work listed

Allison Fitzgerald

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2814-0481; OpenAlex author ID A5057564512; NIH RePORTER profile ID 15547201. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 grant

Papers 2

DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarci… Co-author DOI 10.1136/jitc-2021-002837 ↗
Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. Co-author DOI 10.1158/2326-6066.cir-20-0272 ↗

Grants 1

The Potential Role of Firboblast Activation Protein as a Natural Killer Cell Immune Checkpoint in Pancreatic Cancer F30CA239441 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Elana Judith Fertig · 2 shared papers, 2021 · strength 0.22
- Paper DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murin… DOI 10.1136/jitc-2021-002837 ↗
- Paper Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. DOI 10.1158/2326-6066.cir-20-0272 ↗
Louis M. Weiner · 2 shared papers, 2021 · strength 0.22
- Paper DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murin… DOI 10.1136/jitc-2021-002837 ↗
- Paper Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. DOI 10.1158/2326-6066.cir-20-0272 ↗
Zoe X. Malchiodi · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. DOI 10.1158/2326-6066.cir-20-0272 ↗
Reham Ajina · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. DOI 10.1158/2326-6066.cir-20-0272 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.